União Europeia -
esloveno -
EMA (European Medicines Agency)
vaborem
menarini international operations luxembourg s.a. - meropenem trihidrat, vaborbactam - urinary tract infections; bacteremia; bacterial infections; respiratory tract infections; pneumonia; pneumonia, ventilator-associated - antibacterials za sistemsko uporabo, - vaborem je indicirano za zdravljenje naslednjih okužb pri odraslih:zapleteno okužbo sečil (cuti), vključno z pyelonephritiscomplicated znotraj trebušne okužbe (ciai)bolnišnično pridobljene pljučnice (hap), vključno z ventilator, povezanih pljučnica (vap). zdravljenje bolnikov z bacteraemia, ki se pojavlja v povezavi z ali obstaja sum, da je povezana z, vse okužbe, ki so navedene zgoraj. vaborem je tudi navedeno, za zdravljenje okužb zaradi aerobni gram-negativne organizmov pri odraslih z omejenimi možnosti zdravljenja. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.
Eslovênia -
esloveno -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
primolut nor 5 mg tablete
bayer d.o.o. - noretisteronacetat - tableta - noretisteronacetat 5 mg / 1 tableta - noretisteron
Eslovênia -
esloveno -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
fungiconazol
dechra regulatory -
Eslovênia -
esloveno -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
dalmaprost
support pharma -
Eslovênia -
esloveno -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
sugamadeks sandoz 100 mg/ml raztopina za injiciranje
sugamadeks - raztopina za injiciranje - sugamadeks 100 mg / 1 ml - sugamadeks
União Europeia -
esloveno -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
União Europeia -
esloveno -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - zavrnitev nevromuskularne blokade, ki jo inducira rocuronium ali vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
União Europeia -
esloveno -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskularna blokada - sugamadeks - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
União Europeia -
esloveno -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Eslovênia -
esloveno -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
lutogin 100 mg kapsule
sanolabor, d.d. - kapsula, trda - progesteron